Fortitude Family Office’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$977 Sell
297
-151
-34% -$503 ﹤0.01% 2255
2026
Q2
$1.29K Buy
+448
New +$1.14K ﹤0.01% 1657
2025
Q4
– Sell
-3
Closed -$13 – 1996
2025
Q3
$13 Hold
3
– – ﹤0.01% 1973
2025
Q2
$15 Buy
+3
New +$13 ﹤0.01% 2022

Other funds holding GDRX

Fortitude Family Office's GDRX Position: Q3 2026 in Review

Fortitude Family Office reduced its GoodRx Holdings (GDRX) stake by 34% in Q3 2026, selling an estimated $503 and leaving 297 shares worth $977. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Fortitude Family Office first reported a position in GDRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.29K in Q2 2026. 10 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Fortitude Family Office held 297 shares of GoodRx Holdings worth $977 as of Q3 2026.
  • Fortitude Family Office sold 151 GoodRx Holdings shares in Q3 2026, an estimated $503.
  • GoodRx Holdings made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2255 holding.
  • Fortitude Family Office first reported a position in GoodRx Holdings in Q2 2025 and has held it in 4 quarters since.
  • Fortitude Family Office's GoodRx Holdings position peaked at $1.29K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.